Résultats de la recherche - 33 results
Prevention of Cervical Cancer: Guideline of the DGGG and the DKG (S3 Level, AWMF Register Number 015/027OL, December 2017)- Part 2 on Triage, Treatment and Follow-up.
neoplasia (CIN) cervical precancerous condition HPV Abstract: EN AIMS Annual opportunistic screening for cervical carcinoma has been done in Germany since 1971. The creation of this S3 guideline meets an ...
Prevention of Cervical Cancer: Guideline of the DGGG and the DKG (S3 Level, AWMF Register Number 015/027OL, December 2017)- Part 1 with Introduction, Screening and the Pathology of Cervical Dysplasia.
neoplasia (CIN) cervical precancerous condition HPV Abstract: AIMS Annual opportunistic screening for cervical carcinoma has been carried out in Germany since 1971. The creation of this S3 guideline meets an ...
Impact of the human papillomavirus status on the development of high-grade cervical intraepithelial neoplasia in women negative for intraepithelial lesions or malignancy at the baseline: A 9-year Swedish nested case-control follow-up study.
led to the use of sensitive HPV molecular tests for screening. This study examined the impact of the baseline HPV status on the future risk of cervical intraepithelial neoplasia grade 2 or worse (CIN2 ...
Pathways to a cancer-free future: A protocol for modelled evaluations to maximize the future impact of interventions on cervical cancer in Australia
cancer Cervical cancer prevention EVALUATION Health economics Modelling Simulation Abstract: OBJECTIVE Australia’s HPV vaccination and HPV-based cervical screening programs are changing the landscape in ...
Cervical morbidity in Alsace, France: results from a regional organized cervical cancer screening program.
program of cervical cancer screening was introduced in the Alsace region, France. Women aged 25-65 years were proposed to have one Pap smear every 3 years. The objective was to assess cervical morbidity in ...
Detecting cervical precancer and reaching underscreened women by using HPV testing on self samples: updated meta-analyses.
Volume 363 (2018) Keywords: Colposcopy Early Detection of Cancer Female Humans incidence Intention to Treat Analysis Mass Screening Papillomaviridae Papillomavirus Infections Randomized Controlled Trials ...
Clinical and Analytical Evaluation of the Anyplex II HPV HR Detection Assay within the VALGENT-3 Framework.
the cobas 4800 HPV test (cobas). The panel comprises 1,300 stored samples that were obtained from women 25 to 64 years old who participated in the Slovenian cancer screening program, enriched with 300 ...
Validation of intra- and inter-laboratory reproducibility of the Xpert HPV assay according to the international guidelines for cervical cancer screening.
Keywords: Confidence Intervals DNA, Viral Early Detection of Cancer Female Genotyping Techniques Human Papillomavirus DNA Tests Humans Mass Screening Papillomaviridae Papillomavirus Infections Practice ...
VALHUDES: A protocol for validation of human papillomavirus assays and collection devices for HPV testing on self-samples and urine samples
C Cocuzza; F H Zhao; S Van Keer; A Vorsters Source: J Clin Virol, Volume 107 (2018) Keywords: cervical cancer diagnostic test accuracy SCREENING self-sampling Test validation Urine collection VALHUDES ...
Clinical Evaluation of INNO-LiPA HPV Genotyping II Assay Using the VALGENT Framework.
with abnormal cytology obtained from women attending the Slovenian cervical cancer screening programme. The INNO-LiPA allows type-specific detection of 32 HPV types; however, for the clinical accuracy ...